Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced on October 27, 2025, that it purchased 555,000 of its ordinary shares, with a nominal value of 31¼ pence each, on October 24, 2025. The shares were bought through BNP Paribas SA, with the lowest price paid per share being 1,597.50p and the highest being 1,638.50p; the volume-weighted average price was 1,619.90p. These shares will be held as treasury shares, and the purchase is part of an existing buyback program announced on September 30, 2025. Since that date, GSK has purchased 6,282,500 ordinary shares. Following this transaction, GSK holds 253,747,344 ordinary shares in treasury and has 4,061,673,442 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 6.25%.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings